Ausgabe 4/2024
Inhalt (23 Artikel)
Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome
Yee-Jen Wu, Chien-Chih Wu, Hsin-Yi Huang, Chi-Yun Wu, Ching-Chang Huang, Chi-Chuan Wang
Antithrombotic strategies for preventing graft failure in coronary artery bypass graft
Maria Sara Mauro, Simone Finocchiaro, Dario Calderone, Carla Rochira, Federica Agnello, Lorenzo Scalia, Davide Capodanno
Impact of hemodialysis on efficacies of the antiplatelet agents in coronary artery disease patients complicated with end-stage renal disease
Zekang Ye, Qin Wang, Inam Ullah, Qingxia Lin, Tianyu Wu, Mingwen Yang, Yuansheng Fan, Zhou Dong, Tong Wang, Jianzhen Teng, Rui Hua, Yingdan Tang, Yule Li, Xiaoxuan Gong, Liang Yuan, Zhengxian Tao, Chunjian Li
Development of a routine bedside CYP2C19 genotype assessment program for antiplatelet therapy guidance in a community hospital catheterization laboratory
Paul A. Gurbel, Kevin Bliden, Matthew Sherwood, Hamid Taheri, Behnam Tehrani, Marjaneh Akbari, Shahram Yazdani, Juzer Ali Asgar, Rahul Chaudhary, Udaya S. Tantry
Impact of rise and fall phases of shear on platelet activation and aggregation using microfluidics
Xuemei Gao, Tiancong Zhang, Xiaojing Huang, Xuanrong Huan, Yuan Li
A systematic review of therapeutic enoxaparin dosing in obesity
Maya R. Chilbert, Kimberly Zammit, Uzma Ahmed, Amanda Devlin, Sara Radparvar, Ashley Schuler, Ashley E. Woodruff
Management of direct oral anticoagulant drug interactions in hospitalized patients
Mohsen H. Al Zaria, Leo F. Buckley, Heather Dell’orfano, Peter Manzo, John Fanikos
Retrospective, multicenter analysis of the safety and effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesity
Jeffrey D. Sperry, Aletha Loeb, Melissa J. Smith, Tessa B. Brighton, Julie A. Ehret, Joli D. Fermo, Morgan E. Gentili, Jason W. Lancaster, Jennifer N. Mazur, Katherine Spezzano, Jennifer A. Szwak
Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa
Julius Chacha Mwita, Joel Msafiri Francis, Chriselda Pillay, Okechukwu S. Ogah, Dejuma Yadeta Goshu, Francis Agyekum, John Mukuka Musonda, Maduka Chiedozie James, Endale Tefera, Tsie Kabo, Keolebile Irene Ditlhabolo, Kagiso Ndlovu, Ayoola Yekeen Ayodele, Wigilya P. Mkomanga, Pilly Chillo, Albertino Damasceno, Aba Ankomaba Folson, Anthony Oyekunle, Erius Tebuka, Fredrick Kalokola, Karen Forrest, Helena Dunn, Kamilu Karaye, Fina Lubaki Jean-Pierre, Chala Fekadu Oljira, Tamirat Assefa Tadesse, Tolulope Shogade Taiwo, Chibuike E. Nwafor, Olufemi Omole, Raphael Anakwue, Karen Cohen
One-year morbidity and mortality in patients treated with standard-dose and low-dose apixaban after acute large vessel occlusion stroke
Yasutaka Murakami, Kenichi Todo, Kazutaka Uchida, Hiroshi Yamagami, Nobuyuki Sakai, Yasufumi Gon, Shuhei Okazaki, Tsutomu Sasaki, Shinichi Yoshimura, Takeshi Morimoto, Hideki Mochizuki
The incidence of major bleeding in adult patients with urogenital and gynecological cancer being treated with direct oral anticoagulants (DOACs): a systematic review
L. Al-Tourah, S. Mithoowani, W Lim, Rick Ikesaka
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database
Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Superficial vein thrombosis and its relationship with malignancies: a prospective observational study
Alejandro Díez-Vidal, Javier Gómez López, Pablo Rodríguez Fuertes, Fabián Tejeda Jurado, Paula Berrocal Espinosa, Juan Francisco Martínez Ballester, Sonia Rodríguez Roca, María Angélica Rivera Núñez, Ana María Martínez Virto, Yale Tung-Chen
A ten-year comparison of treatment and outcomes of cancer-associated thrombosis to non-cancer venous thromboembolism: from traditional anticoagulants to direct oral anticoagulants
Benjamin Wee, Jeffrey Lai, Zille Khattak, Anna Kwok, Cynthia Donarelli, Prahlad Ho, Hui Yin Lim, Brandon Lui
Prediction of mortality in acute pulmonary embolism in cancer-associated thrombosis (MAUPE-C): derivation and validation of a multivariable model
Mario Aramberri, Jesús González-Olmedo, Adrián García-Villa, Ane Villanueva, Cristina Castillo Maza, Susana García-Gutiérrez, Carmen Diaz-Pedroche
Management of DOAC-related bleeding in cancer patients: a single center-case series
Sophia Lee, Jeremy A. Ross, Ali Zalpour, Jason T. Henry, Cristhiam M. Rojas Hernandez
Discrimination of the acute pulmonary embolism subtypes based on the novel MAPH score
Onur Akhan, Mustafa Boz, Tuncay Guzel, Mehmet Kis
Is a minimum duration of 5 days of unfractionated heparin infusion necessary before transition to oral anticoagulation in cerebral venous thrombosis? a retrospective chart review
Ariel N. Carrion, Teresa A. Allison, Sophie Samuel
Therapeutic implication of MicroRNA-320a antagonist in attenuating blood clots formed during venous thrombosis
Swati Srivastava, Iti Garg, Nilanjana Ghosh, Rajeev Varshney
Outcomes of venous thromboembolism in patients with inherited thrombophilia treated with direct oral anticoagulants: insights from the RIETE registry
Omri Cohen, Gili Kenet, Sarina Levy-Mendelovich, Inna Tzoran, Benjamin Brenner, Cristina De Ancos, Patricia López-Miguel, José F. Varona, Judith Catella, Manuel Monreal, M. D. Adarraga, A. Alberich-Conesa, J. Aibar, A. Alda-Lozano, J. Alfonso, C. Amado, M. Angelina-García, J. I. Arcelus, A. Ballaz, R. Barba, C. Barbagelata, M. Barrón, B. Barrón-Andrés, F. Beddar-Chaib, A. Blanco-Molina, J. Criado, C. De Ancos, J. Del Toro, P. Demelo-Rodríguez, C. De Juana-Izquierdo, J. A. Díaz-Peromingo, A. Dubois-Silva, J. C. Escribano, C. Falgá, A. I. Farfán-Sedano, C. Fernández-Aracil, C. Fernández-Capitán, B. Fernández-Jiménez, J. L. Fernández-Reyes, M. A. Fidalgo, I. Francisco, C. Gabara, F. Galeano-Valle, F. García-Bragado, C. García-González, A. García-Ortega, O. Gavín-Sebastián, A. Gil-Díaz, A. M. Gómez, C. Gómez-Cuervo, E. Grau, L. Guirado, J. Gutiérrez, L. Hernández-Blasco, L. Jara-Palomares, M. J. Jaras, D. Jiménez, R. Jiménez, I. Jou, M. D. Joya, R. Lecumberri, J. M. León-Ramírez, J. L. Lobo, L. López-Jiménez, P. López-Miguel, J. J. López-Núñez, A. López-Ruiz, J. B. López-Sáez, A. Lorenzo, M. Lumbierres, O. Madridano, A. Maestre, P. J. Marchena, M. Marcos, M. Martín del Pozo, F. Martín-Martos, J. M. Maza, E. Mena, M. I. Mercado, J. Moises, M. Monreal, M. V. Morales, M. S. Navas, J. A. Nieto, M. J. Núñez-Fernández, M. Olid, L. Ordieres-Ortega, M. Ortiz, J. Osorio, S. Otálora, R. Otero, N. Pacheco-Gómez, J. Pagán, A. C. Palomeque, E. Paredes, P. Parra, J. M. Pedrajas, C. Pérez-Ductor, M. A. Pérez-Jacoiste, M. Pérez-Pinar, M. L. Peris, M. L. Pesce, J. A. Porras, R. Puchades, F. Rivera-Cívico, A. Rodríguez-Cobo, V. Rosa, M. Romero-Brugera, P. Ruiz-Artacho, N. Ruiz-Giménez, J. Ruiz-Ruiz, G. Salgueiro, T. Sancho, V. Sendín, P. Sigüenza, S. Soler, S. Suárez-Fernández, R. Tirado, C. Tolosa, A. Torrents-Vilar, M. I. Torres, J. Trujillo-Santos, E. Usandizaga, F. Uresandi, R. Valle, J. F. Varona, G. Vidal, A. Villalobos, P. Villares, C. Ay, S. Nopp, I. Pabinger, T. Vanassche, P. Verhamme, A. Verstraete, H. H. B. Yoo, A. C. Montenegro, S. N. Morales, J. Roa, J. Hirmerova, R. Malý, L. Bertoletti, A. Bura-Riviere, J. Catella, R. Chopard, F. Couturaud, O. Espitia, C. Grange, B. Leclercq, R. Le Mao, I. Mahé, F. Moustafa, L. Plaisance, G. Sarlon-Bartoli, P. Suchon, E. Versini, S. Schellong, B. Brenner, N. Dally, I. Tzoran, P. Sadeghipour, F. Rashidi, G. Barillari, M. Basaglia, F. Bilora, B. Brandolin, M. Ciammaichella, D. Colaizzo, F. Dentali, P. Di Micco, E. Grandone, E. Imbalzano, C. Marcon, R. Pesavento, A. Poz, P. Prandoni, C. Siniscalchi, B. Taflaj, A. Tufano, A. Visonà, B. Zalunardo, R. Paluga, A. Skride, D. Kigitovica, S. Fonseca, R. Marques, J. Meireles, S. Pinto, M. Bosevski, M. Trajkoca, M. Zdraveska, H. Bounameaux, L. Mazzolai, A. Aujayeb, J. A. Caprini, I. Weinberg, H. M. Bui, Manuel Monreal, Paolo Prandoni, Benjamin Brenner, Dominique Farge-Bancel, Raquel Barba, Pierpaolo Di Micco, Laurent Bertoletti, Sebastian Schellong, Inna Tzoran, Abilio Reis, Marijan Bosevski, Henri Bounameaux, Radovan Malý, Peter Verhamme, Joseph A. Caprini, Hanh My Bui
Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity
Erica Okazaki, Bárbara Gomes Barion, Tania Rubia Flores da Rocha, Giovanna Di Giacomo, Yeh-Li Ho, Cynthia Rothschild, Giancarlo Fatobene, Bruna del Guerra de Carvalho Moraes, Bianca Stefanello, Paula Ribeiro Villaça, Vanderson Geraldo Rocha, Fernanda Andrade Orsi
COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment
Li-Hua Liu, Yang-Zhao Zhou, Tian-Yu Li, Da-Bin Kuang, Qun Liang, Lei Chen, Da-Feng Yang, Xia Zhang, Sheng-Lan Tan
Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate
Richard J Buka, David J Sutton, Phillip LR Nicolson